samedan logo
 
 
 
spacer
home > ebr > winter 2001 > 9th annual biopartnering europe event
PUBLICATIONS
European Biopharmaceutical Review

9th Annual BioPartnering Europe Event

The formula and track record for Technology Vision Group's annual partnering event is now well-established at the Queen Elizabeth Conference Centre in London. Every year it successfully brings together senior biotech and pharma representatives from all over the world, as well as investors, consultants, lawyers and regional groups. This year's event was no exception with over 1,100 delegates attending to make maximal use of the networking opportunities and technology showcases. There was also the chance to hear from some well known industry names voicing a view on the status of the sector in Q4, 2001.As in previous years, albeit amid tighter security on this occasion, the meeting kicked off with the regional delegation receptions on the Sunday evening. These featured both national and regional biotechnology associations from a range of European and North American territories, including for the first time 'Invest Australia'.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
By Dr Helen Abbott, Editor of EBR
spacer
Dr Helen Abbott
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Team Consulting expands facilities to meet client demand

To meet growing client demand, Team Consulting, a medical device design and development consultancy based in Ickleton, Cambridge, has expanded its facilities to now offer over 5,500 sq ft of lab spaces. Based in the picturesque 13th century Abbey Barns site, the company’s expansion sees the addition of a whole new building with several high-spec lab spaces, design facilities and collaborative workspaces.
More info >>

White Papers

High-tech Packaging for High-tech Medicine

West Pharmaceutical Services, Inc.

As more biologics and biosimilars come on to the global pharmaceutical market, they can and will present unique packaging and containment challenges. For materials that are sensitive to glass or that may require larger-dose volumes or custom configurations, cyclic olefin polymers may offer a solution. These novel materials for drug container closure systems can provide a needed alternative to traditional glass containment systems for advanced therapeutics.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement